AURAYA

Serial Number 98095822
653

Registration Progress

Application Filed
Jul 21, 2023
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

AURAYA

Basic Information

Serial Number
98095822
Filing Date
July 21, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
653
Status Date
Sep 9, 2024
Application
Pending
Classes
005

Rights Holder

PRIOVANT THERAPEUTICS, INC.

03
Address
151 W. 42ND STREET
15TH FLOOR
NEW YORK, NY 10036

Ownership History

Roivant Sciences GmbH

Original Applicant
99
Basel CH

PRIOVANT THERAPEUTICS, INC.

New Owner Before Publication #1
03
NEW YORK, NY

Legal Representation

Attorney
Lisa L. Mueller

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

15 events
Date Code Type Description Documents
Apr 21, 2025 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Loading...
Sep 9, 2024 GNSL F LETTER OF SUSPENSION E-MAILED Loading...
Sep 9, 2024 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Sep 9, 2024 CNSL R SUSPENSION LETTER WRITTEN Loading...
May 1, 2024 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Mar 1, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Mar 1, 2024 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Loading...
Mar 1, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Mar 1, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Mar 1, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 1, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 1, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Feb 26, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 21, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 25, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for human use; biologic preparations for medical and therapeutic purposes; pharmaceutical preparations to treat inflammatory diseases and disorders and diseases and disorders of the immune system; pharmaceutical preparations to treat dermatomyositis, systemic lupus erythematosus (SLE), hidradenitis suppurativa, scleroderma, sarcoidosis, juvenile dermatomyositis, and non-infectious uveitis

Classification

International Classes
005